This review highlights deoxynojirimycin's role in glucose regulation in type 2 diabetes, suggesting additional health benefits in obesity and lipid metabolism.
Key Points
Deoxynojirimycin is a natural compound that inhibits α-glucosidase, effectively regulating blood glucose levels.
Research shows DNJ may help manage type 2 diabetes, obesity, and improve lipid metabolism.
The extraction and purification processes for DNJ have been optimized to enhance yield and bioavailability.
DNJ's diverse effects include antiviral, antimicrobial, and hepatoprotective properties, expanding its therapeutic potential.